
CPHI & PMEC China 2026
06/2026 – 06/2026
Established in 1966, Hisoar Pharmaceutical is a public company located in Taizhou, Zhejiang, China, with turnover reaching $147 million in 2009. As one of the leading pharmaceutical companies in China, Hisoar supplies human and veterinary APIs under cGMP facilities, including antibiotics/anti-inflammatories, anti-diabetics, anti-HIV drugs and cardiovascular products, also providing high-quality, cost-effective fine chemicals and intermediates, with rich experience in contract manufacturing for multinational pharmaceutical companies.

No comments available.
Leave your rating & comment